AMGEN Inc.

A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More

Pharma M&A Shows an Industry Looking to Specialize

Next Phase of Pharma Growth: Generics

Big Pharma and The Need for Speed

An Easy Way to Profit Off One of Today’s Strongest Sectors

Yumanity Therapeutics To Cut 60% of Staff, Explore Strategic Options